Clover Health

Today's 1Q26 earnings release demonstrates how market-leading growth and GAAP profitability can scale together at full risk in Medicare Advantage. Highlights: - We achieved positive GAAP Net Income in first-quarter 2026, marked by strong performance across our key metrics: Total Revenues, Adjusted EBITDA, and Consolidated Gross Profit. - We had market-leading MA membership growth with underlying trends tracking in line with expectations. - We expect to meet or exceed our full year 2026 outlook across all metrics, including achieving our first full year of GAAP Net Income profitability. Here’s the full release on what we delivered this quarter, in Clay Thornton’s first earnings as our Interim CFO: investors.cloverhealth.com/static-files/1…

What does healthcare AI look like when a computer scientist-led health plan holds the risk? Our CEO @andrewtoy joined @BainCapital's Future of Healthcare AI podcast, on why the payer is one of the few vantage points from which you can truly re-architect healthcare with technology. Also: why the right 80s movie for agentifying solutions isn't Terminator. 🎙 baincapital.com/healthcare/med…

🎉 We've got a Jeopardy! champion in our midst. Huge congratulations to our very own, Tristan Williams, Staff Data Scientist, who won last night’s episode of Jeopardy! Turns out data scientists are pretty good at knowing things. Tristan returns today, Thursday May 7, for round two. Tune in to see if he can break the one-day champion curse! 📺 We're cheering you on, Tristan! 🟦 🟦 🟦

Last week, Clover and @counterparthlth had the honor of participating in the Centers for Medicare & Medicaid Services Health Tech Ecosystem: Live! First Wave Launch. On stage, Counterpart Chief Product Officer @kevinholub shared how we’re advancing digital health tools that enable members to securely request and share their clinical and claims data. Inspired by the collective progress and by the many teams across health tech building toward a better, more connected healthcare experience.

Clover Health Q1 2026 earnings results are set for release on Wednesday, May 6, 2026. Our CLOV Supplemental Q&A submissions form is now open and we plan to publish responses the week following earnings. Please submit all questions for CEO Andrew Toy via our IR website anytime between now and 4:30pm ET on Tuesday, April 28. We look forward to hearing from you! Access our Q&A submissions form here: forms.gle/8N2CwigYCKynU7…

Healthcare AI just showed up at the Webbys. 🏆 The Clover Health Broker Assistant is a 2026 @TheWebbyAwards nominee in AI – Customer Experience or CRM. We built it to take the complexity out of Medicare Advantage for the brokers on the front lines helping people find the right plan for them. Voting is open through April 16, every vote counts and we'd appreciate your support. 👉 wbby.co/58831N

Building on recent interoperability milestones, Clover is partnering with @HealthEx_io to empower our MA members to securely request and share clinical and claims data through digital health tools. This collaboration, powered by @counterparthlth infrastructure, is now live and provides members with control over their health data without needing to navigate multiple portals or separate logins. Read the full press release: investors.cloverhealth.com/news-releases/…

We are proud to see @counterparthlth’s latest whitepaper highlight the impact of preventive intelligence at the point of care.

We recently announced that nationwide, interoperable data exchange is not aspirational, it is achievable today. At #HIMSS26, CMS selected Clover Health to demo live on the mainstage. @kevinholub joined Amy Gleason to show it in action. In the workflow, @fastenhealth supports the patient application connecting to the network, @Kno2 securely routes patient-directed requests, @counterparthlth enables the exchange, and Clover responds as the payer. investors.cloverhealth.com/news-releases/…

Proud to be part of the @Kno2 Connected™ ecosystem. Today at HIMSS 2026, Clover Health, @Kno2, and @counterparthlth are demonstrating our production-ready capability for real-time, patient-directed data exchange - showing how a patient request flows through the network and returns structured clinical and claims data. See it in action at #HIMSS26, Booth #12720. investors.cloverhealth.com/news-releases/…

Thanks to those who took the time to submit thoughtful questions for this quarter’s Supplemental Q&A. For Q425, we’ve answered a focused set of shareholder questions that we believe provide additional context on our performance in 2025, our priorities for 2026, and the longer-term trajectory of the business. These questions reflect submissions received through our shareholder portal, as well as recurring themes from recent conversations with investors and participants at industry conferences. Read more: investors.cloverhealth.com/static-files/8…

Today’s 4Q25 and FY 2025 earnings release reaffirms our ability to deliver strong MA performance and meaningful membership growth across a wide-network PPO, while continuing to lead the nation on HEDIS quality. Highlights: - We generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year. - We achieved industry-leading 2026 AEP growth of 53% year-over-year paired with strong returning member retention. - We expect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026. Read our full earnings release: investors.cloverhealth.com/static-files/7…

Best question we got this week: "I'm an accountant who builds custom picnic tables. Do you want me?" Did you improve on the design? Did you do something new (a new joint system that reuses scrap material. the most comfortable table ever. whatever!) - we want YOU. This isn’t for someone that just follows the path another person laid out. We're looking for product people, makers and builders. cloverhealth.com/commit

Clover Health Q4 and full-year 2025 earnings results are set for release on Thursday, February 26, 2026 with our accompanying CLOV Supplemental Q&A to go live the week after. Please submit all questions for CEO Andrew Toy and CFO Peter Kuipers via our IR website anytime between now and 4:30pm ET on Thursday, February 12. We look forward to hearing from you! Access our Q&A submissions form: forms.gle/9DkZDmuDKeqcxP…

Big news: we've grown our MA membership during AEP by 53%, increasing to ~153k members as of 1/1/26. Disciplined core-market growth, strong member retention & improving cohort economics establish a strong path to achieve first full-year GAAP Net Income profitability in 2026. @andrewtoy will present at #JPMHC26 tomorrow to discuss how these results fit into our longer-term strategy. Visit our investor website for more details and access via webcast. More on AEP: investors.cloverhealth.com/news-releases/…

Small Moments. Big Outcomes. Our new video shows how complete data and timely insights at the point of care can change a patient’s course of care. This is the future of value-based care. Read more about Counterpart’s 2025 results: investors.cloverhealth.com/news-releases/…

At Counterpart Health, we’re delivering measurable, sustained improvement in quality, risk, and total cost of care, starting with @CloverHealth and expanding rapidly to new clinicians.

We’re grateful to those who took the time to engage with us and submit thoughtful questions for this quarter’s Supplemental Q&A. This time around, we’ve answered a focused set of questions designed to offer deeper insight into our strategic direction. These questions were chosen from shareholder submissions as well as recurring themes from recent investor discussions and conferences. To continue the conversation, please email our investor relations team at investors@cloverhealth.com. Read more: investors.cloverhealth.com/static-files/e…